688068 Stock Overview
Beijing Hotgen Biotech Co., Ltd. engages in the research, development, manufacture, and sale of medical and public safety inspection products of in-vitro diagnostic products in the field of biomedicine.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 2/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Beijing Hotgen Biotech Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥28.14 |
52 Week High | CN¥55.88 |
52 Week Low | CN¥23.67 |
Beta | 1.6 |
1 Month Change | -14.57% |
3 Month Change | -21.37% |
1 Year Change | -40.14% |
3 Year Change | -71.30% |
5 Year Change | n/a |
Change since IPO | -41.25% |
Recent News & Updates
Shareholder Returns
688068 | CN Life Sciences | CN Market | |
---|---|---|---|
7D | -6.1% | -6.5% | -0.2% |
1Y | -40.1% | -45.5% | -17.8% |
Return vs Industry: 688068 exceeded the CN Life Sciences industry which returned -45.5% over the past year.
Return vs Market: 688068 underperformed the CN Market which returned -17.8% over the past year.
Price Volatility
688068 volatility | |
---|---|
688068 Average Weekly Movement | 9.9% |
Life Sciences Industry Average Movement | 9.6% |
Market Average Movement | 8.9% |
10% most volatile stocks in CN Market | 12.7% |
10% least volatile stocks in CN Market | 5.4% |
Stable Share Price: 688068's share price has been volatile over the past 3 months.
Volatility Over Time: 688068's weekly volatility (10%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2005 | 1,367 | Changqing Lin | www.hotgen.com.cn |
Beijing Hotgen Biotech Co., Ltd. engages in the research, development, manufacture, and sale of medical and public safety inspection products of in-vitro diagnostic products in the field of biomedicine. It offers drug detection, CDC, Up-conversion luminescence technology, colloidal gold, CLIA, sugar capture, microfluidic, and gene detection products for testing of intestinal microorganisms, gastrointestinal foodborne infections, insect-borne diseases, respiratory pathogens, infectious diseases, Ebola virus antigen, biological warfare agents, microorganisms, and mycotoxins. Beijing Hotgen Biotech Co., Ltd.
Beijing Hotgen Biotech Co., Ltd. Fundamentals Summary
688068 fundamental statistics | |
---|---|
Market cap | CN¥2.50b |
Earnings (TTM) | CN¥30.16m |
Revenue (TTM) | CN¥541.15m |
83.4x
P/E Ratio4.6x
P/S RatioIs 688068 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
688068 income statement (TTM) | |
---|---|
Revenue | CN¥541.15m |
Cost of Revenue | CN¥0 |
Gross Profit | CN¥541.15m |
Other Expenses | CN¥510.99m |
Earnings | CN¥30.16m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 30, 2024
Earnings per share (EPS) | 0.34 |
Gross Margin | 100.00% |
Net Profit Margin | 5.57% |
Debt/Equity Ratio | 0.6% |
How did 688068 perform over the long term?
See historical performance and comparison